![Kenneth P. H. Pritzker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth P. H. Pritzker
Fondatore presso Rna Diagnostics, Inc.
Posizioni attive di Kenneth P. H. Pritzker
Società | Posizione | Inizio | Fine |
---|---|---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 01/01/2010 | - |
Fondatore | 01/01/2010 | - |
Storia della carriera di Kenneth P. H. Pritzker
Precedenti posizioni note di Kenneth P. H. Pritzker
Società | Posizione | Inizio | Fine |
---|---|---|---|
CARERX CORPORATION | Direttore/Membro del Consiglio | 25/06/2009 | 25/06/2009 |
Statistiche
Distribuzione geografica
Canada | 3 |
Posizioni
Director/Board Member | 2 |
Founder | 1 |
Settori
Health Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CARERX CORPORATION | Health Services |
Aziende private | 1 |
---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Health Technology |